MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia

K. Ohta, T. Nakajima (Kashiwazaki city Niigata, Japan)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1137

Keywords: Dementia, Dysphagia, Rehabilitation

Category: Parkinsonism, Others

Objective: The clinical and neuroimaging factors associated with dysphagia were investigated in this retrospective data of Parkinson’s disease (PD) patients.

Background: PD can cause dysphagia that usually worsens the prognosis. The clinical characteristics, especially factors associated with dysphagia are poorly understood. The problem is that it is not easy to assess swallowing function in outpatient clinics.

Method: A total of 104 patients, the patients with Hoehn and Yahr’s (HY) stage III or higher who visited our hospital in 2017 were included and those who underwent DBS and those with a family history were excluded. The degree of dysphagia was classified into six stages. Multiple regression analysis was performed between the degree of dysphagia and the following factors including age, sex, duration of illness, cognitive impairment, autonomic nervous symptoms, depression, hallucinations, HY stage, ADL, modified Rankin scale (mRS) score, respiratory dysfunction, and initial symptoms. In the subgroup analysis of the patients who underwent brain dopamine transporter single-photon emission computed tomography (DaT-SPECT) using 123I-ioflupane, the specific binding ratio (SBR) values were statistically compared between the patients who require to change in diet and others. Similarly, patients who received 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 123I-IMP SPECT were subgrouped and analyzed for differences between those two groups.

Results: Severe respiratory disorders, high severity on the HY classification, and cognitive impairment were highly correlated with the severity of dysphagia. The SBR in the group requiring a change in dietary form in the basal ganglia was low on DaT-SPECT, but there was no significant difference in H/M ratio in the early and late phases. 123I-IMP SPECT showed no significant difference in cerebral blood flow between the two groups.

Conclusion: High HY stage, low SBR, and cognitive impairment were important factors in causing dysphagia in PD patients. In such patients, it is important to consider swallowing function assessment, swallowing rehabilitation, and dietary changes. The lack of a significant difference between the two groups on 123I-IMP SPECT might suggest that the role of the cerebral cortex in the swallowing function in PD patients is relatively small.

To cite this abstract in AMA style:

K. Ohta, T. Nakajima. Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-and-nuclear-neuroimaging-features-of-parkinsons-disease-with-dysphagia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-nuclear-neuroimaging-features-of-parkinsons-disease-with-dysphagia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley